Delivery Order SPE2DB22D2009-SPE2DB24FL7WT
Award Date 1/24/24
Potential Completion Date 1/25/24
Potential Value $1.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of EXFORGE 5-160 MG TABLET 30S. The order has a completion date of January 26, 2024 and a potential value of $2,679.45. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of pharmaceutical products and medical supplies to U.S. government agencies, including the Department of Defense. This...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The $3,938.44 order is for the delivery of EXFORGE 5-160 MG TABLET 30S, a pharmaceutical product, to support DLA Troop Support Medical operations. The contract has a completion date of January 23, 2024. Amerisourcebergen Drug Corp, through its Corporate Office...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,089.05 contract is for the provision of 4563783806 EXFORGE 5-320 MG TABLET 30S, a pharmaceutical product, with a completion date of February 28, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA with a potential value of $999,999,999.00 and a performance period...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide EXFORGE 10-320 MG TABLET 30S for a potential value of $1,504.44. The contract has a completion date of February 20, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31,...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract worth $3,419.41 by the Defense Logistics Agency (DLA) to provide EXFORGE 5-160 MG TABLET 30S, a pharmaceutical product, with a completion date of January 26, 2024. This award is part of Amerisourcebergen Drug Corp's broader role as the prime contractor on an indefinite delivery contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distributor. The $2,151.25 contract is for the supply of EXFORGE 5-160 MG TABLET 30S, a pharmaceutical product. No set-aside designation was used. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical, valued at up to...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,166.39 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide EXFORGE 5-160 MG TABLET 30S pharmaceuticals. This order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary vehicle for...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for EXFORGE 5-320 MG TABLET 30S. The $1,537.16 firm fixed-price contract has a completion date of November 29, 2024 and was awarded on November 27, 2024. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a for-profit organization registered in the System for Award Management (SAM.gov) and maintains an Indefinite Delivery...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical to provide EXFORGE 5-160 MG TABLET 30S, a pharmaceutical product, with a potential value of $1,071.78. The contract has a completion date of February 7, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor on this award, which does not have a set-aside designation....
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide EXFORGE HCT 10-160-25 MG TAB 30S. This $1,225.14 award has a completion date of February 23, 2024. Amerisourcebergen Drug Corp is the prime contractor and this order is part of a larger indefinite delivery contract (IDC) it holds with DLA, potentially valued at up to $999,999,999.00 through December 31, 2025. This IDC serves as the...
- SPE2DB22D2009Indefinite Delivery Contract
- SPE2DB22D2009-SPE2DB24FL7WTDelivery Order
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 30-tablet bottles of the pharmaceutical product EXFORGE 5-160 MG TABLET. The $1,327.29 contract has a completion date of January 25, 2024. Amerisourcebergen Drug Corp is a prime contractor that has received numerous federal contract awards from DLA to provide pharmaceuticals, medical supplies, and distribution services in support of military treatment programs and facilities. No set-aside designation was used for this specific award.
Generated 4/24/24, 10:48 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 1/24/24 |